CLINICAL_TRIALS
trial_result
· 2019-06-06
Clinical Trial Update: Dose Ranging Study of SPL7013 Gel for Treatment of Bacterial Vaginosis (BV) [Phase 2]
Summary
Phase 2 dose-ranging trial of SPL7013 gel for bacterial vaginosis has completed and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Starpharma Pty Ltd | Conditions: Bacterial Vaginosis | Phase 2 | Status: COMPLETED | Results posted: 2019-06-06